{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:33Z","timestamp":1791318333150,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejim.2018.01.023","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T08:04:09Z","timestamp":1519977849000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"special_numbering":"C","title":["Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4349-3442","authenticated-orcid":false,"given":"Lihi","family":"Bar-Lev Schleider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Lederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Hilou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Lencovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Betzalel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Shbiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Novack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.01.023_bb0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejim.2018.01.023_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejim.2018.01.023_bb0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejim.2018.01.023_bb0020","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejim.2018.01.023_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejim.2018.01.023_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0305-7372(84)90010-0","article-title":"Advances in anti-emetic therapy","volume":"11","author":"Bakowski","year":"1984","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejim.2018.01.023_bb0035","first-page":"5","article-title":"Chemotherapy-induced nausea and vomiting: clinician and patient perspectives","volume":"5","author":"Schwartzberg","year":"2007","journal-title":"J Support Oncol"},{"key":"10.1016\/j.ejim.2018.01.023_bb0040","unstructured":"National Academies of Sciences E, and Medicine. The Health Effects of Cannabis and Cannabinoids: the Current State of Evidence and Recommendations for Research. National Academies Press."},{"key":"10.1016\/j.ejim.2018.01.023_bb0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/02791072.2011.587700","article-title":"Who are medical marijuana patients? Population characteristics from nine California assessment clinics","volume":"43","author":"Reinarman","year":"2011","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.ejim.2018.01.023_bb0050","first-page":"1022","article-title":"Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis","volume":"17","author":"Ferraz","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2018.01.023_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.ejim.2018.01.023_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","author":"Group W","year":"1998","journal-title":"Psychol Med"},{"key":"10.1016\/j.ejim.2018.01.023_bb0065","series-title":"Market Size and Demand for Marijuana in Colorado","first-page":"202014","volume":"209","author":"Light","year":"2014"},{"key":"10.1016\/j.ejim.2018.01.023_bb0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.drugalcdep.2013.04.019","article-title":"Characteristics of adults seeking medical marijuana certification","volume":"132","author":"Ilgen","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ejim.2018.01.023_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","article-title":"An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics","volume":"46","author":"Johnson","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejim.2018.01.023_bb0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.ejim.2018.01.023_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/SPC.0000000000000056","article-title":"Opioids and cancer recurrence","volume":"8","author":"Juneja","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ejim.2018.01.023_bb0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/j.1532-2149.2013.00401.x","article-title":"Extended-release opioids in the management of cancer pain: a systematic review of efficacy and safety","volume":"18","author":"Mesgarpour","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ejim.2018.01.023_bb0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/theoncologist.2012-0269","article-title":"Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids","volume":"18","author":"Reddy","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.ejim.2018.01.023_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/510392","article-title":"The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care","volume":"2013","author":"Bar-Sela","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejim.2018.01.023_bb0105","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1377\/hlthaff.2015.1661","article-title":"Medical marijuana laws reduce prescription medication use in medicare part D","volume":"35","author":"Bradford","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.ejim.2018.01.023_bb0110","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","article-title":"Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"Boehnke","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.ejim.2018.01.023_bb0115","series-title":"Cannabis and Cannabinoid Research","first-page":"160","article-title":"Cannabis as a substitute for opioid-based pain medication: patient self-report","volume":"2","author":"Reiman","year":"2017"},{"key":"10.1016\/j.ejim.2018.01.023_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1300\/J069v19n03_07","article-title":"Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members","volume":"19","author":"Harris","year":"2000","journal-title":"J Addict Dis"},{"key":"10.1016\/j.ejim.2018.01.023_bb0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","article-title":"Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use","volume":"24","author":"Walsh","year":"2013","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ejim.2018.01.023_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7517-2-18","article-title":"Survey of Australians using cannabis for medical purposes","volume":"2","author":"Swift","year":"2005","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.ejim.2018.01.023_bb0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1742-1241.2004.00271.x","article-title":"The medicinal use of cannabis in the UK: results of a nationwide survey","volume":"59","author":"Ware","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejim.2018.01.023_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1533210107301834","article-title":"Medical cannabis patients: patient profiles and health care utilization patterns","volume":"12","author":"Reiman","year":"2007","journal-title":"Complement Health Pract Rev"},{"key":"10.1016\/j.ejim.2018.01.023_bb0145","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1200\/JCO.2013.52.5188","article-title":"Principles of opioid use in cancer pain","volume":"32","author":"Portenoy","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2018.01.023_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0885-3924(92)90116-Y","article-title":"Long-term oral opioid therapy in patients with chronic nonmalignant pain","volume":"7","author":"Zenz","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejim.2018.01.023_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-3959(80)90077-9","article-title":"The effects of detoxification, relaxation, and brief supportive therapy on chronic pain","volume":"8","author":"Taylor","year":"1980","journal-title":"Pain"},{"key":"10.1016\/j.ejim.2018.01.023_bb0160","first-page":"S105","article-title":"Opioid complications and side effects","volume":"11","author":"Ricardo Buenaventura","year":"2008","journal-title":"Pain Physician"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518300232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518300232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T13:53:01Z","timestamp":1535032381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518300232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":32,"alternative-id":["S0953620518300232"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.01.023","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}